Dossier · GRPN · Dormant
GRPN · Groupon, Inc. · Stock research
Last analysed ·
Current thesis
AI-native restructuring re-rate up to 400 job cuts, FY26 EBITDA guide raised to $75–80M plus a low-float, Russell-inclusion squeeze that popped GRPN +10% on 2026-07-16. But Q1 billings fell 1% YoY and sell-side sits at Sell: a maturing turnaround with squeeze optionality, with the ~2026-08-06 Q2 print as the binary.
Invalidation trigger
A weekly close below $22 surrenders the mid-July Russell-inclusion squeeze base and signals the passive bid plus short-covering have exhausted; a Q2 print near 2026-08-06 with billings below flat or a cut to the raised $75–80M EBITDA guide confirms the turnaround has stalled.
Thesis status
Open commitment catalyst in 11dscored if the trigger above fires How this is scored →Latest analysis and events for GRPN —
As of 2026-07-25, orbyd's latest analysis for Groupon, Inc. (GRPN): AI-native restructuring re-rate up to 400 job cuts, FY26 EBITDA guide raised to $75–80M plus a low-float, Russell-inclusion squeeze that popped GRPN +10% on 2026-07-16. But Q1 billings fell 1% YoY and sell-side sits at Sell: a maturing turnaround with squeeze optionality, with the ~2026-08-06 Q2 print as the binary.
Invalidation trigger: A weekly close below $22 surrenders the mid-July Russell-inclusion squeeze base and signals the passive bid plus short-covering have exhausted; a Q2 print near 2026-08-06 with billings below flat or a cut to the raised $75–80M EBITDA guide confirms the turnaround has stalled.
Next dated event on file: — catalyst in 11d.
Current Thesis
The investable leg is an "AI-native" restructuring re-rate stacked on squeeze mechanics. In late May 2026 management announced cutting up to 400 roles (~15% of global headcount) for $20–25M of annual savings, which lifted the FY26 adjusted-EBITDA guide to $75–80M (from $70–75M) alongside a stated goal of at least $60M free cash flow. Layered on a heavily-shorted low float and a late-June reclassification into the Russell Value indices, that produced a +10% squeeze on 2026-07-16. The problem: Q1 2026 global billings fell 1% YoY with revenue flat, sell-side consensus is Sell, the average 12-month target ($26.33) sits essentially at spot ($25.81), and the stock trades ~40% under its $43.08 52-week high. This is a maturing turnaround carrying squeeze optionality rather than an accelerating narrative the ~2026-08-06 Q2 print is the arbiter.
Bullish and bearish views on Groupon, Inc.
The model's bull view on Groupon, Inc. (GRPN), in brief: FY26 adjusted-EBITDA guide raised to $75–80M and a stated FCF target of at least $60M with billings +3–5% (Q1 2026 commentary). The bear view: Growth is decelerating: Q1 2026 global billings −1% YoY and revenue flat, with North America local slowing the inverse of the setup this book exists to catch. Both cases follow in full.
Bull Case
- FY26 adjusted-EBITDA guide raised to $75–80M and a stated FCF target of at least $60M with billings +3–5% (Q1 2026 commentary). A first genuinely FCF-positive year re-rates a former value trap off a low base.
- The cost lever is dated and concrete: up to 400 roles (~15% of headcount) cut for $20–25M annual savings, announced late May 2026, dropping largely to EBITDA in a business that already finished its cloud re-platform.
- Squeeze fuel is real: a large portion of the float sits short, and the late-June 2026 move into the Russell Value indices forced passive buying that drove the +10% pop on 2026-07-16. A billings/EBITDA beat on ~2026-08-06 into that positioning can force covering toward the $40 Street high.
- Capital return that tightens the float: 2.8M shares repurchased in Q1 2026, shrinking an already-small tradeable share count.
- Project Foundry embedding AI agents into SEO, app development, and merchant acquisition via voice agents hands the tape a fresh label distinct from the dead "daily deals" frame.
Bear Case
- Growth is decelerating: Q1 2026 global billings −1% YoY and revenue flat, with North America local slowing the inverse of the setup this book exists to catch.
- Sell-side consensus is Sell as of 2026-07-16, and the average target $26.33 sits at the $25.81 price there is no analyst-upgrade runway to front-run.
- Management instability mid-restructuring: COO Jiri Ponrt resigned effective 2026-07-10, raising execution risk on the very cost plan the bull case leans on.
- The 2026-07-16 advance was a mechanical squeeze on index rebalancing, not a fundamental inflection; those fade once the passive bid completes and shorts re-establish.
- Q2 consensus EPS is −$0.06 still loss-making at the reported line; a repeat of the Q1 weather excuse or a billings print below flat would erode the raised EBITDA guide's credibility.
- Price is ~40% under the $43.08 52-week high in a sloppy mid-range structure; "cheap versus the high" is an anchor, not a setup.
Setup & Price Structure
- Last $25.81 (2026-07-24); day range $25.23–$26.49; 52-week range $9.17–$43.08.
- The name has already run a full mania cycle ($9 → $43 → mid-$20s) and now trades mid-range above the July squeeze base but far below the highs, with no clean higher-low breakout and no peer cluster confirming (Groupon is idiosyncratic; there is no local-commerce peer group breaking out alongside it).
- The 2026-07-16 +10% squeeze built a near-term shelf in the low-$20s; holding it keeps the squeeze leg alive, losing it hands the tape back to shorts.
- The $26.33 average target caps consensus upside, with the $40 high estimate as the squeeze-case ceiling and the $13 low estimate marking the bear downside.
- For a fresh entry this reads as stand-aside-until-it-bases-or-prints: a fat float-adjusted range and a binary print roughly eight sessions out mean chasing the squeeze here is buying into an event, so waiting for a base or the number is the higher-quality path.
Catalyst Calendar (next 30 days)
- ~2026-08-06 (est.) Q2 2026 earnings after the close (one source cites 2026-08-12; confirm the date). Consensus EPS −$0.06. The print grades the raised $75–80M EBITDA guide, the billings trajectory against the Q1 −1%, and whether the 400-role cut is flowing through. This is the binary.
- Ongoing Russell Value index flows from the late-June inclusion; passive rebalancing can persist into the print and amplify moves in a low float.
Elapsed catalysts
- Watch any 8-K on further restructuring (Q1 flagged a "potential 15% headcount reduction") or additional executive departures following the 2026-07-10 COO exit. _(passed 16d ago)_
What Would Change Our Mind
Bull-confirm: a Q2 print (~2026-08-06) with billings back to positive YoY and the $75–80M EBITDA / $60M FCF guide reaffirmed or raised, holding a weekly close above the mid-$20s squeeze shelf, would flip the read from maturing to re-accelerating and justify sizing up. Thesis break: a weekly close below $22 surrenders the mid-July Russell-inclusion squeeze base and signals the passive bid and short-covering have exhausted; a Q2 billings print below flat or a trim to the raised $75–80M EBITDA guide converts the AI-restructuring story back into a value trap.
Correlation Notes
- Idiosyncratic name: GRPN moves on company-specific squeeze mechanics and restructuring headlines, not on a consumer-discretionary factor beta the "consumer-discretionary-rotation" tag is a loose classifier rather than a tradable cluster.
- Behaves like a low-float short-squeeze vehicle, correlated more to short-interest and borrow-cost dynamics and to index-rebalancing flow than to XLY or any local-commerce peer set.
- Sentiment reads off retail squeeze chatter and borrow availability rather than sell-side, which sits at Sell (2026-07-16) with the average target pinned at spot.
Notes
- Q2 2026 earnings ~2026-08-06 after close (one source says 2026-08-12) confirm date; avoid fresh entries into the print given low float + binary risk.
- Low float + elevated short interest: moves are squeeze-driven (July 16 +10% on Russell Value index inclusion). Size tight, probe only, never chase the pop.
- Sell-side at Sell (2026-07-16); avg 12-mo PT $26.33 ~ at spot $25.81 no analyst-upgrade runway to front-run. High estimate $40, low $13.
- COO Jiri Ponrt resigned effective 2026-07-10 mid-restructuring watch for further exec departures / 8-K restructuring actions.
- Q1 2026 was a miss: global billings -1% YoY, revenue flat, North America local decelerating; 2.8M-share buyback executed.
Related · shared themes
MRCY
Mercury Systems Inc
Defense-electronics turnaround re-rating inside an accelerating modernization tape: Q3 FY26 (2026-05-06) printed record bookings $348M (+73.7% YoY), 1.48 book-to-bill, record ~$1.6B backlog and +46% EBITDA, with FCF guided positive. But the stock just reversed ~16% off its $128.45 ATH; the ~2026-08-10 Q4/full-year print is the next binary.
SNX
TD SYNNEX Corporation
Q2 blowout (rev $19.575B vs $16.8B est, 6/25) broke the seasonal guide-down bear case and the sell-side is chasing higher (MS $374, UBS $352). The channel re-rating is now confirmed by fundamentals, but the catalyst is spent and the next binary is ~3 months out current levels chase the post-earnings gap rather than buy the setup.
XMTR
Xometry, Inc.
AI-native manufacturing marketplace re-rating on a profitability inflection Q1 marketplace revenue +40% YoY, FY guide raised, Siemens embed plus ~$50M stock buy. Wedbush 7/16 Outperform $126 reopens Street upside above spot after June's above-cluster trade; the ~2026-08-06 Q2 print is the next binary.
DELL
Dell Technologies Inc.
Enterprise AI-server rebuild intact fundamentally (+757% YoY AI-server revenue), but the tape broke: 2026-07-15 reversed 13% from near-record high to $397 as the memory complex and SMCI sold off. Lower high vs the $475.40 ATH, momentum books exited in 24h, and no dated catalyst until Q2 FY27 in late August.
See also · stocks to watch